Susan Miesfeldt

2.7k total citations
48 papers, 1.6k citations indexed

About

Susan Miesfeldt is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, Susan Miesfeldt has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 15 papers in Public Health, Environmental and Occupational Health and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Susan Miesfeldt's work include BRCA gene mutations in cancer (23 papers), Palliative Care and End-of-Life Issues (9 papers) and Genetic factors in colorectal cancer (9 papers). Susan Miesfeldt is often cited by papers focused on BRCA gene mutations in cancer (23 papers), Palliative Care and End-of-Life Issues (9 papers) and Genetic factors in colorectal cancer (9 papers). Susan Miesfeldt collaborates with scholars based in United States, Tanzania and Canada. Susan Miesfeldt's co-authors include Craig B. Thompson, Donald W. Hadley, Noralane M. Lindor, Gloria M. Petersen, Karen H. Lu, Wylie Burke, Patrick M. Lynch, Nancy Press, Anita Y. Kinney and Wendy Cohn and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Susan Miesfeldt

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Miesfeldt United States 17 564 498 432 343 301 48 1.6k
Ilana Cass United States 25 625 1.1× 646 1.3× 313 0.7× 461 1.3× 206 0.7× 69 2.4k
Joan Murphy Canada 21 532 0.9× 675 1.4× 320 0.7× 177 0.5× 274 0.9× 43 2.1k
Adam N. Rosenthal United Kingdom 24 501 0.9× 519 1.0× 199 0.5× 594 1.7× 182 0.6× 69 2.3k
Eloise Chapman‐Davis United States 22 549 1.0× 325 0.7× 154 0.4× 222 0.6× 263 0.9× 95 1.6k
Sarah E. Ferguson Canada 31 768 1.4× 217 0.4× 300 0.7× 183 0.5× 213 0.7× 161 3.0k
Thomas C. Randall United States 25 548 1.0× 277 0.6× 99 0.2× 356 1.0× 211 0.7× 83 2.3k
Julian Sanchez United States 20 715 1.3× 332 0.7× 375 0.9× 346 1.0× 137 0.5× 56 1.9k
Judy Kirk Australia 30 826 1.5× 1.3k 2.6× 614 1.4× 579 1.7× 641 2.1× 107 3.1k
B.J. Rimel United States 23 1.4k 2.5× 424 0.9× 171 0.4× 760 2.2× 197 0.7× 113 2.6k
Kristen M. Shannon United States 19 419 0.7× 771 1.5× 570 1.3× 342 1.0× 131 0.4× 43 1.5k

Countries citing papers authored by Susan Miesfeldt

Since Specialization
Citations

This map shows the geographic impact of Susan Miesfeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Miesfeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Miesfeldt more than expected).

Fields of papers citing papers by Susan Miesfeldt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Miesfeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Miesfeldt. The network helps show where Susan Miesfeldt may publish in the future.

Co-authorship network of co-authors of Susan Miesfeldt

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Miesfeldt. A scholar is included among the top collaborators of Susan Miesfeldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Miesfeldt. Susan Miesfeldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salako, Omolola, Susan Miesfeldt, Mamsau Ngoma, et al.. (2023). Remote Symptom Monitoring to Enhance the Delivery of Palliative Cancer Care in Low-Resource Settings: Emerging Approaches from Africa. International Journal of Environmental Research and Public Health. 20(24). 7190–7190. 1 indexed citations
2.
Anderson, Eric, Emily Edelman, Petra Helbig, et al.. (2021). Patients' Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology Practices. JCO Precision Oncology. 5(5). 1554–1562. 5 indexed citations
3.
Boehmer, Leigh, Latha Shivakumar, Christine B. Weldon, et al.. (2020). BRCA testing concordance with national guidelines for patients with breast cancer in community cancer programs.. Journal of Clinical Oncology. 38(15_suppl). 1526–1526.
4.
Lucas, F. Lee, et al.. (2017). Examination of the Patient-Focused Impact of Cancer Telegenetics Among a Rural Population: Comparison with Traditional In-Person Services. Telemedicine Journal and e-Health. 24(2). 130–138. 44 indexed citations
5.
Miesfeldt, Susan, et al.. (2013). Management of Genetic Syndromes Predisposing to Gynecologic Cancers. Current Treatment Options in Oncology. 14(1). 34–50. 6 indexed citations
6.
Lee, Clara, Mirhelen Mendes de Abreu, Annie LeBlanc, et al.. (2011). Interprofessional education about decision support for patients: What are the high-priority research issues?. Journal of Interprofessional Care. 25(6). 428–430. 3 indexed citations
7.
Murray, K, et al.. (2011). Intensity of end-of-life cancer care among seniors: Variations by principal health care provider.. Journal of Clinical Oncology. 29(15_suppl). 9132–9132. 1 indexed citations
8.
9.
Cohn, Wendy, Mary E. Ropka, Mable B. Kinzie, et al.. (2010). Health Heritage<sup>©</sup>, a Web-Based Tool for the Collection and Assessment of Family Health History: Initial User Experience and Analytic Validity. Public Health Genomics. 13(7-8). 477–491. 73 indexed citations
10.
11.
12.
Lucas, F. Lee, et al.. (2008). Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer. BMC Cancer. 8(1). 38–38. 30 indexed citations
13.
Zbuk, Kevin, et al.. (2007). Germline mutations in PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paraganglioma. Nature Clinical Practice Oncology. 4(10). 608–612. 25 indexed citations
14.
Lindor, Noralane M., Gloria M. Petersen, Donald W. Hadley, et al.. (2006). Recommendations for the Care of Individuals With an Inherited Predisposition to Lynch Syndrome. JAMA. 296(12). 1507–1507. 2 indexed citations
15.
Miesfeldt, Susan, et al.. (2003). Breast cancer survivors' attitudes about communication of breast cancer risk to their children. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 119C(1). 45–50. 27 indexed citations
16.
Miesfeldt, Susan, Wendy Cohn, Mary E. Ropka, & Susan Jones. (2001). Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors. Familial Cancer. 1(3-4). 135–141. 11 indexed citations
17.
Miesfeldt, Susan, et al.. (2000). Men’s attitudes regarding genetic testing for hereditary prostate cancer risk. Urology. 55(1). 46–50. 29 indexed citations
18.
Cooney, Kathleen A., Hui C. Tsou, Elizabeth M. Petty, et al.. (1999). Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.. PubMed. 5(6). 1387–91. 13 indexed citations
19.
Cooney, Kathleen A., Ethan M. Lange, Lan Huang, et al.. (1998). Prostate Cancer Susceptibility Locus on Chromosome 1q: A Confirmatory Study. The Journal of Urology. 160(1). 264–265. 6 indexed citations
20.
Thompson, Craig B., I‐Cheng Ho, Paul R. Bohjanen, et al.. (1992). cis -Acting Sequences Required for Inducible Interleukin-2 Enhancer Function Bind a Novel Ets-Related Protein, Elf-1. Molecular and Cellular Biology. 12(3). 1043–1053. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilana Cass Breakdown of academic impact, for papers by Joan Murphy Breakdown of academic impact, for papers by Adam N. Rosenthal Breakdown of academic impact, for papers by Eloise Chapman‐Davis Breakdown of academic impact, for papers by Sarah E. Ferguson Breakdown of academic impact, for papers by Thomas C. Randall Breakdown of academic impact, for papers by Julian Sanchez Breakdown of academic impact, for papers by Judy Kirk Breakdown of academic impact, for papers by B.J. Rimel Breakdown of academic impact, for papers by Kristen M. Shannon
Rankless by CCL
2026